Late-Stage Modification of Medicine: Pd-Catalyzed Direct Synthesis and Biological Evaluation of N‑Aryltacrine Derivatives
Main Authors: | Lin-Xi Wan, Yong-Qi Zhen, Zhen-Xiang He, Yang Zhang, Lan Zhang, Xiaohuan Li, Feng Gao, Xian-Li Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2021-04-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.1c01404 |
Similar Items
-
Peptide-guided functionalization and macrocyclization of bioactive peptidosulfonamides by Pd(II)-catalyzed late-stage C–H activation
by: Jian Tang, et al.
Published: (2018-08-01) -
Evidence for in Situ Catalyst Modification during the Pd-Catalyzed Conversion of Aryl Triflates to Aryl Fluorides
by: Maimone, Thomas, et al.
Published: (2013) -
Impact of hydronium ions on the Pd-catalyzed furfural hydrogenation
by: Iris K. M. Yu, et al.
Published: (2022-11-01) -
Pd/C-Catalyzed Intramolecular C–H Arylation for the Synthesis of Phenanthridinones and Dibenzo-α-pyrones
by: Lingyu Zhao, et al.
Published: (2017-03-01) -
Late-stage diversification by rutheniumelectro-catalyzed C–H mono- and di-acyloxylation
by: Haiwei Shen, et al.
Published: (2020-11-01)